These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 26108135

  • 1. The incidence of thrombocytopenia associated with continuous renal replacement therapy in critically ill patients.
    Ferreira JA, Johnson DW.
    Ren Fail; 2015 Aug; 37(7):1232-6. PubMed ID: 26108135
    [Abstract] [Full Text] [Related]

  • 2. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S, Guzzo I, Solazzo A, Muzi L, Luciani R, Pierucci A.
    J Nephrol; 2003 Aug; 16(4):566-71. PubMed ID: 14696760
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of Thrombocytopenia in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
    Droege CA, Ernst NE, Messinger NJ, Burns AM, Mueller EW.
    Ann Pharmacother; 2018 Dec; 52(12):1204-1210. PubMed ID: 29871503
    [Abstract] [Full Text] [Related]

  • 4. The clinical diagnosis of heparin-induced thrombocytopenia in patients receiving continuous renal replacement therapy.
    Holmes CE, Huang JC, Cartelli C, Howard A, Rimmer J, Cushman M.
    J Thromb Thrombolysis; 2009 May; 27(4):406-12. PubMed ID: 18488144
    [Abstract] [Full Text] [Related]

  • 5. Association of Thrombocytopenia and Mortality in Critically Ill Patients on Continuous Renal Replacement Therapy.
    Guru PK, Singh TD, Akhoundi A, Kashani KB.
    Nephron; 2016 May; 133(3):175-82. PubMed ID: 27380175
    [Abstract] [Full Text] [Related]

  • 6. Argatroban for anticoagulation in continuous renal replacement therapy.
    Link A, Girndt M, Selejan S, Mathes A, Böhm M, Rensing H.
    Crit Care Med; 2009 Jan; 37(1):105-10. PubMed ID: 19050602
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Influence of time of initiation of continuous renal replacement therapy on prognosis of critically ill patients with acute kidney injury].
    Hu ZJ, Liu LX, Zhao CC.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jul; 25(7):415-9. PubMed ID: 23834940
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Complications During Continuous Renal Replacement Therapy in Critically Ill Neonates.
    Nishimi S, Sugawara H, Onodera C, Toya Y, Furukawa H, Konishi Y, Sotodate G, Matsumoto A, Ishikawa K, Oyama K.
    Blood Purif; 2019 Jul; 47 Suppl 2():74-80. PubMed ID: 30943473
    [Abstract] [Full Text] [Related]

  • 11. The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients.
    Crowther MA, Cook DJ, Albert M, Williamson D, Meade M, Granton J, Skrobik Y, Langevin S, Mehta S, Hebert P, Guyatt GH, Geerts W, Rabbat C, Douketis J, Zytaruk N, Sheppard J, Greinacher A, Warkentin TE, Canadian Critical Care Trials Group.
    J Crit Care; 2010 Jun; 25(2):287-93. PubMed ID: 20149589
    [Abstract] [Full Text] [Related]

  • 12. Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial.
    Crowther M, Cook D, Guyatt G, Zytaruk N, McDonald E, Williamson D, Albert M, Dodek P, Finfer S, Vallance S, Heels-Ansdell D, McIntyre L, Mehta S, Lamontagne F, Muscedere J, Jacka M, Lesur O, Kutsiogiannis J, Friedrich J, Klinger JR, Qushmaq I, Burry L, Khwaja K, Sheppard JA, Warkentin TE, PROTECT collaborators, Canadian Critical Care Trials Group, Australian and New Zealand Intensive Care Society Clinical Trials Group.
    J Crit Care; 2014 Jun; 29(3):470.e7-15. PubMed ID: 24726205
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Single-dose application of antithrombin as a potential alternative anticoagulant during continuous renal replacement therapy in critically ill patients with advanced liver cirrhosis: a retrospective data analysis.
    Brunner R, Leiss W, Madl C, Druml W, Holzinger U.
    Anesth Analg; 2013 Mar; 116(3):527-32. PubMed ID: 23400980
    [Abstract] [Full Text] [Related]

  • 16. Influence of Daily Fluid Balance prior to Continuous Renal Replacement Therapy on Outcomes in Critically Ill Patients.
    Han MJ, Park KH, Shin JH, Kim SH.
    J Korean Med Sci; 2016 Aug; 31(8):1337-44. PubMed ID: 27478348
    [Abstract] [Full Text] [Related]

  • 17. Fluid removal associates with better outcomes in critically ill patients receiving continuous renal replacement therapy: a cohort study.
    Hall A, Crichton S, Dixon A, Skorniakov I, Kellum JA, Ostermann M.
    Crit Care; 2020 Jun 01; 24(1):279. PubMed ID: 32487189
    [Abstract] [Full Text] [Related]

  • 18. Does early initiation of continuous renal replacement therapy affect outcome: experience in a tertiary care center.
    Vats HS, Dart RA, Okon TR, Liang H, Paganini EP.
    Ren Fail; 2011 Jun 01; 33(7):698-706. PubMed ID: 21787161
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.